Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Clover Health is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-09Current report (material event)
- 8-K/A2026-09-25Current report (amended)
- 8-K2026-09-24Current report (material event)
- 8-K2026-08-20Current report (material event)
- 10-Q2026-08-07Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-07-17Current report (material event)
- 8-K2026-06-18Current report (material event)
- 8-K2026-06-16Current report (material event)
- 8-K2026-06-12Current report (material event)
- 8-K2026-06-10Current report (material event)
- 8-K2026-05-18Current report (material event)
- 10-Q2026-05-08Quarterly report
- 8-K2026-05-06Current report (material event)
- ARS2026-04-28Annual report to holders
- DEFA14A2026-04-28DEFA14A
- DEF 14A2026-04-28Proxy statement
- 8-K2026-04-01Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- S-82026-03-10Employee stock plan
- 8-K/A2026-03-06Current report (amended)
- 8-K2026-03-06Current report (material event)
- 10-K2026-02-27Annual report
- 8-K2026-02-26Current report (material event)
- 8-K2026-01-14Current report (material event)
- 8-K2025-12-10Current report (material event)
- 8-K2025-11-12Current report (material event)
- 10-Q2025-11-07Quarterly report
- 8-K2025-11-04Current report (material event)
- 8-K2025-10-31Current report (material event)
- 8-K2025-10-09Current report (material event)
- 8-K2025-08-11Current report (material event)
- 10-Q2025-08-08Quarterly report
- 8-K2025-08-05Current report (material event)
- SCHEDULE 13G2025-07-29SCHEDULE 13G
- SCHEDULE 13G2025-07-17SCHEDULE 13G
- 8-K2025-06-12Current report (material event)
- 8-K2025-05-14Current report (material event)
- 10-Q2025-05-09Quarterly report
- 8-K2025-05-06Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.